Franklin Resources’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-52,623
| Closed | -$1.13M | – | 3235 |
|
|
2026
Q1 | $1.13M | Sell |
52,623
-103
| -0.2% | -$1.45K | ﹤0.01% | 2136 |
|
|
2025
Q4 | $491K | Sell |
52,726
-3,424,300
| -98% | -$28.6M | ﹤0.01% | 2413 |
|
|
2025
Q3 | $24.5M | Sell |
3,477,026
-620,599
| -15% | -$4.27M | 0.01% | 885 |
|
|
2025
Q2 | $26.6M | Buy |
4,097,625
+79,255
| +2% | +$545K | 0.01% | 839 |
|
|
2025
Q1 | $31.9M | Buy |
4,018,370
+135,418
| +3% | +$1.46M | 0.01% | 753 |
|
|
2024
Q4 | $49.2M | Buy |
3,882,952
+13,320
| +0.3% | +$185K | 0.01% | 622 |
|
|
2024
Q3 | $55.3M | Buy |
3,869,632
+87,262
| +2% | +$1.25M | 0.02% | 564 |
|
|
2024
Q2 | $52.1M | Sell |
3,782,370
-24,420
| -0.6% | -$357K | 0.02% | 543 |
|
|
2024
Q1 | $62.9M | Sell |
3,806,790
-430,005
| -10% | -$6.44M | 0.02% | 502 |
|
|
2023
Q4 | $61.9M | Buy |
4,236,795
+169,463
| +4% | +$2.05M | 0.03% | 443 |
|
|
2023
Q3 | $49.9M | Buy |
4,067,332
+1,664
| +0% | +$21.7K | 0.03% | 494 |
|
|
2023
Q2 | $48.5M | Buy |
4,065,668
+658,797
| +19% | +$8.6M | 0.02% | 529 |
|
|
2023
Q1 | $45.5M | Buy |
3,406,871
+934,022
| +38% | +$18.2M | 0.02% | 547 |
|
|
2022
Q4 | $53.2M | Sell |
2,472,849
-3,857
| -0.2% | -$79.1K | 0.03% | 511 |
|
|
2022
Q3 | $49.6M | Buy |
2,476,706
+11,326
| +0.5% | +$241K | 0.03% | 525 |
|
|
2022
Q2 | $44.1M | Buy |
2,465,380
+922,521
| +60% | +$9.53M | 0.02% | 578 |
|
|
2022
Q1 | $15.3M | Buy |
1,542,859
+581,633
| +61% | +$7.68M | 0.01% | 918 |
|
|
2021
Q4 | $16.2M | Buy |
961,226
+370,699
| +63% | +$7.62M | 0.01% | 945 |
|
|
2021
Q3 | $14M | Buy |
590,527
+71,561
| +14% | +$1.71M | 0.01% | 976 |
|
|
2021
Q2 | $11.8M | Buy |
+518,966
| New | +$10.8M | ﹤0.01% | 984 |
|
Other funds holding DAWN
Franklin Resources's DAWN Position: Q2 2026 in Review
Franklin Resources sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 52,623 shares — an estimated $1.13M sold.
Franklin Resources first reported a position in DAWN in Q2 2021 and held it in 20 quarters. The position peaked at $62.9M in Q1 2024. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Franklin Resources reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Franklin Resources sold 52,623 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.13M.
- Franklin Resources first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 20 quarters.
- Franklin Resources's Day One Biopharmaceuticals position peaked at $62.9M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.